• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Horizons in Cancer Research. Volume 54

Horizons in Cancer Research. Volume 54

9781633213890
1 140,24 zł
1 026,21 zł Zniżka 114,03 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 1 026,21 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
This book presents original results on the leading edge of cancer research. Topics discussed include the risk factors, diagnosis and treatment options for glioblastoma; the biology of the interleukin-2 (il-2)-based immunotherapies in cancer and autoimmune disease; rna interference (rnai)/rna activation (rnaa) for cancer therapeutics; melanoma progression to metastatic disease; proteins, polysaccharide-peptide complexes and polysaccharides with antiproliferative and anticancer activities of mushrooms; low-molecular-weight compounds with anticancer activity of mushroom origin; lifestyle and cancer prevention; and the pathology and pathogenesis of Hodgkins lymphoma.
Szczegóły produktu
74632
9781633213890
9781633213890

Opis

Rok wydania
2014
Numer wydania
1
Oprawa
twarda
Liczba stron
227
Wymiary (mm)
178.00 x 254.00
Waga (g)
556
  • PrefaceGlioblastoma:: Risk Factors, Diagnosis and Treatment Options(André Ballesteros-Tato, Troy D. Randall, Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA)The Biology of the Interleukin-2 (IL-2)-Based Immunotherapies in Cancer and Autoimmune Disease(André Ballesteros-Tato, Troy D. Randall, Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA)OFF or ON:: RNA Interference (RNAi) / RNA Activation (RNAa) for Cancer Therapeutics(Sorah Yoon, John J. Rossi, Department of Molecular and Cellular Biology, Beckman Research, Institute of City of Hope, Duarte, California, USA)Melanoma Progression to Metastatic Disease:: The Role of the PI3K/AKT and Wnt/β-Catenin Pathways(Jaskiran Sidhu, Geetha Venkateswaran, Sujata Persad, Department of Pediatrics Faculty of Medicine and Dentistry University of Alberta, Edmonton, Alberta, Canada)For Complete Table of Contents, please visit our website athttps:://www.novapublishers.com/catalog/product_info.php?cPath=23_29&products_id=50487
Komentarze (0)